Advisor Net Financial, Inc Immunity Bio, Inc. Transaction History
Advisor Net Financial, Inc
- $1.27 Billion
- Q1 2025
A detailed history of Advisor Net Financial, Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 4,268 shares of IBRX stock, worth $12,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,268
Previous 2,143
99.16%
Holding current value
$12,334
Previous $5,000
160.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IBRX
# of Institutions
232Shares Held
82.3MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$50.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$33 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$28.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$11.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.16B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...